Delivery Order SPE2DB20D2002-SPE2DB26FL00Q
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,268.58 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This non-competitive, firm fixed price delivery order was awarded on November 6, 2025, with an ultimate completion date of November 7, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This $38,127.91 firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $11,416.55 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This firm fixed-price delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,459.01 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This firm fixed price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by April 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $6,601.44 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,929.86 for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitively awarded, firm fixed-price contract was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,641.16 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely-used anticoagulant medication. The order, issued on October 28, 2025, with an ultimate completion date of October 29, 2025, was competitively awarded without set-aside designation under a firm fixed-price delivery order contract. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,237.75 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure with an ultimate completion date of October 22, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $29,034.73 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 11, 2025. The product will be performed and shipped from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB26FL00QDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication, valued at $11,843.83. This is a firm fixed-price delivery order with an ultimate completion date of October 30, 2025, awarded on October 29, 2025, with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills competitively awarded federal medical procurement needs across multiple therapeutic domains through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 10/29/25 |